Analyst Ratings for Ionis Pharmaceuticals (IONS) [Neutrals]

IONS Rating Summary

IONS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IONS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $59.04 (+61.6%) * Over Last 12-Mos
Rating Score: 4 / 10   Percentile Rank: 37%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/7/2021 UBS Esther Rajavelu Upgrade Neutral
(Sell)
37.50
(33.00)
39.89
(36.54)
-8.4% Details
3/1/2021 Barclays
» Updated 3/23/2021
Gena Wang Upgrade Equalweight
(Underweight)
47.00
(52.00)
53.41
(36.54)
-31.59% Details
Like IONS Ratings? Also take a look at AKCA, BIIB, ACCD, PFE

IONS Ratings News